STAT+: In May, 10 moderate Democrats opposed major drug pricing reform. Ahead of a key vote, that list is shrinking
WASHINGTON — Ten House Democrats fired a warning shot in the spring that they could cause trouble for House Speaker Nancy Pelosi’s signature drug pricing reform legislation. But as the House prepares to vote on a multitrillion-dollar spending bill that appears likely to include those drug pricing policies, it’s almost impossible to imagine all 10 voting against the entire package.
STAT asked each of the 10 lawmakers about their most recent stances on drug pricing — some in brief interviews on Capitol Hill, and some via their congressional offices. Already, two lawmakers have actually endorsed the policy. Several others downplayed their objections to it.
